NeoGenomics, Inc. Debt Securities, Available-for-sale, Current
NeoGenomics, Inc. (NEO) had Debt Securities, Available-for-sale, Current of $182.32 million as of 2022-06-30, per its 10-Q filed 2022-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent · last filed 2022-08-09
- 2022-06-30: Debt Securities, Available-for-sale, Current $182.32M.
- 2022-03-31: Debt Securities, Available-for-sale, Current $175.53M.
- 2021-12-31: Debt Securities, Available-for-sale, Current $198.56M.
- 2021-09-30: Debt Securities, Available-for-sale, Current $202.14M.
| Period end | Debt Securities, Available-for-sale, Current |
|---|---|
| 2022-06-30 | $182.32M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $175.53M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $198.56M 10-Q · filed 2022-08-09 |
| 2021-09-30 | $202.14M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $202.95M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $190.71M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $67.55M 10-K · filed 2022-02-25 |
| 2020-09-30 | $50.38M 10-Q · filed 2020-10-29 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |